LUPKYNIS Drug-use Results Survey
ConditionLupus Nephritis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age15+
SponsorOtsuka Pharmaceutical Co., Ltd.
About this trial
The purpose of this study is to survey the safety of LUPKYNIS in patients with lupus nephritis under actual use conditions. In addition, information on efficacy will be collected.
Eligibility criteria
Qualifiers
Patients who are newly starting administration of LUPKYNIS for lupus nephritis
Disqualifiers
None
Trial design
Treatments tested in this trial
- Voclosporin (LUPKYNIS)
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov